Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 2 | 2 | 0 | 0 | €3.34 | - | - |
| Amgen Inc. | 28 | 0 | 0 | 0 | €300.15 | €304.82 | 1.555% |
| Baxter International | 3 | 0 | 0 | 0 | €35.86 | €46.00 | 28.263% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €138.60 | €145.02 | 4.631% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €50.50 | €50.00 | -0.990% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Prothena Corp. plc | 13 | 0 | 0 | 0 | €18.80 | €78.70 | 318.620% |
| Resmed Inc. | 19 | 0 | 0 | 0 | €224.70 | €216.62 | -3.594% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €53.81 | €55.00 | 2.211% |
| Innoviva Inc. | 6 | 0 | 0 | 0 | €17.50 | €30.00 | 71.429% |
| Ensign Group Inc. | 9 | 0 | 0 | 0 | €138.00 | €125.13 | -9.326% |
| Corcept Therapeutics Inc. | 17 | 0 | 0 | 0 | €32.25 | €36.87 | 14.319% |
| G1 Therapeutics | 19 | 1 | 0 | 0 | €6.45 | €11.09 | 71.926% |
| Omnicell Inc. | 3 | 2 | 0 | 0 | €38.80 | €36.13 | -6.879% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.24 | €1.84 | 676.744% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €22.00 | €28.29 | 28.594% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €95.34 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €10.00 | €10.00 | 0.000% |
| Xencor Inc. | 16 | 0 | 0 | 0 | €18.70 | €31.38 | 67.809% |
| Bio-Techne Corp. | 9 | 0 | 0 | 0 | €67.00 | €75.80 | 13.139% |
| Healthequity Inc. | 2 | 0 | 0 | 0 | €69.00 | €82.25 | 19.203% |
| Charles River Labs Intl | 12 | 0 | 0 | 0 | €175.65 | €247.61 | 40.966% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €196.85 | - | - |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.68 | €4.63 | 174.691% |
| Acadia Healthcare | 1 | 0 | 0 | 0 | €70.00 | - | - |